TrialSignal transduction and targeted therapy2025

A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer.

Zhiwei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.